Company Filing History:
Years Active: 2010-2017
Title: Innovations of James Soothill in Bacteriophage Therapy
Introduction
James Soothill is a notable inventor based in London, GB, recognized for his contributions to the field of bacteriophage therapy. He holds a total of four patents, showcasing his innovative approach to combating bacterial infections.
Latest Patents
One of his latest patents focuses on bacteriophage-containing therapeutic agents. This invention relates to combined phage and antibiotic therapy, specifically the use of one or more bacteriophages alongside one or more antibiotics. The goal is to manufacture a combined product for simultaneous, separate, or sequential administration to treat bacterial infections characterized by biofilm formation. This treatment can be either therapeutic or prophylactic. Additionally, the patent includes deposited bacteriophages that exhibit different strain specificity, including a panel of six bacteriophages effective against a high percentage of clinical isolates from canine ear infections.
Career Highlights
James Soothill has made significant strides in the field of medical innovation, particularly in developing therapies that address complex bacterial infections. His work has the potential to revolutionize treatment options for patients suffering from infections that are resistant to conventional antibiotics.
Collaborations
James collaborates with notable colleagues, including Catherine Hawkins and David R Harper, who contribute to his research and development efforts at Biocontrol Limited.
Conclusion
James Soothill's innovative work in bacteriophage therapy exemplifies the potential of combining traditional antibiotics with phage therapy to enhance treatment efficacy against bacterial infections. His contributions are paving the way for new therapeutic strategies in medicine.